Taylor Morrison Home (TMHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
The annual meeting will be held virtually on May 21, 2026, with shareholders able to vote electronically and submit questions online.
Record date for voting is March 25, 2026; only holders of common stock as of this date may vote.
Four main proposals are up for vote: election of directors, advisory vote on executive compensation, advisory vote on frequency of say-on-pay, and ratification of Deloitte & Touche LLP as auditor.
The board recommends voting FOR all director nominees, FOR executive compensation, FOR annual say-on-pay, and FOR auditor ratification.
Forward-looking statements caution about uncertainties and risks affecting future results.
Voting matters and shareholder proposals
Shareholders will vote on electing eight directors, approving executive compensation, setting the frequency of say-on-pay votes, and ratifying the auditor.
Board recommends annual say-on-pay votes and supports all proposals.
Voting can be done online, by phone, by mail, or during the virtual meeting.
Shareholders may submit other business, but no additional matters are currently anticipated.
Board of directors and corporate governance
Board will reduce to eight members after the meeting; majority are independent under NYSE standards.
Board diversity and tenure are emphasized, with a mix of skills in leadership, finance, technology, and sustainability.
Lead independent director structure is in place; CEO also serves as Chairman, balanced by a lead director.
Board committees (audit, compensation, nominating/governance) are fully independent.
Annual board and committee evaluations, director resignation policy, and robust stock ownership guidelines are enforced.
Latest events from Taylor Morrison Home
- Home closings and margins fell, but liquidity stayed strong and guidance was reaffirmed.TMHC
Q1 202622 Apr 2026 - Director elections, executive pay, and auditor ratification up for vote at 2026 annual meeting.TMHC
Proxy filing10 Apr 2026 - 2025 delivered strong earnings and margins; 2026 outlook expects margin recovery and robust capital returns.TMHC
Q4 202511 Feb 2026 - Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20255 Feb 2026 - Targeting 20,000 closings by 2028 with digital innovation, margin focus, and brand expansion.TMHC
Investor Day 20253 Feb 2026 - Q2 2024 delivered 3,200 closings, $1.99B revenue, and raised full-year guidance.TMHC
Q2 20243 Feb 2026 - Q3 net income up 54% to $251M, with record revenue, margin gains, and strong outlook.TMHC
Q3 202419 Jan 2026 - Double-digit growth in closings and revenue, with strong margins and 2025 outlook.TMHC
Q4 202411 Dec 2025 - Board recommends approval of all proposals, emphasizing governance, pay-for-performance, and ESG.TMHC
Proxy Filing1 Dec 2025